Revolution Medicines, Inc. <RVMD.O>: Stifel raises target price to $230 from $215
RVMD•Related News
America's Car-Mart Q1 revenue falls sharply on inventory constraints
CRMT•
Pet products retailer Chewy's Q2 revenue edges past estimates on recurring sales strength
CHWY•
Deckers Brands: BMO initiates coverage with underperform rating; target price $70
DECK•
Leerink starts Viatris at 'outperform' on improving growth
VTRS•
Chime shares jump 10% as Stride deal puts fintech on path to bank charter
CHYM•